Market capitalization | $7.57m |
Enterprise Value | $12.43m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.39 |
P/S ratio (TTM) P/S ratio | 0.24 |
P/B ratio (TTM) P/B ratio | 1.05 |
Sales growth (TTM) Sales growth | -33.68% |
Turnover (TTM) Turnover | $31.76m |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
1 Analyst has issued a forecast Molecular Templates, Inc.:
1 Analyst has issued a forecast Molecular Templates, Inc.:
Mar '24 | |
Current assets | 11 11 |
Fixed assets | 16 16 |
Total assets | 27 27 |
Mar '24 | |
Equity | 5.87 5.87 |
Debt capital | 21 21 |
Total capital | 27 27 |
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.
Head office | United States |
CEO | Eric Poma |
Employees | 62 |
Founded | 2000 |
Website | www.mtem.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.